Elanco Animal Health has announced the launch of a Milbemax television advertising campaign to educate pet owners about the importance and ease of worming.
The 30-second advertisement will appear as pre-roll to video content on a number of websites from the end of August, and will broadcast on mainstream TV channels including ITV1, Channel 4, Channel Five, Sky, ITV2, ITV3, E4, More4, Film4, UKTV and Five Digital in mid-September to reach an estimated nine million people – of which nearly three million will be identified/targeted pet owners.
Elanco says the advert is designed to target female pet owners between the ages of 25 and 49 and drive them to seek further information and buy pet wormers from their local veterinary surgeon with the call to action: ‘Make an appointment with your vet to find out how easy worming your pet can be.’
Viewers watching the online advertisement will be able to click through to campaign specific pages on Elanco’s WormPatrol website - www.wormpatrol.co.uk/easyworming - where they can use 'Find a Vet', a worm risk checker and worming reminders to connect them with veterinary practices. The advertisement will also be available to view on the WormPatrol website.
The campaign is supported by a range of educational marketing materials and initiatives which are available to Milbemax customers from the vet section of the WormPatrol website or from their local Elanco companion animal territory manager.
The materials include a video to embed in practice websites and to use on social media, a subtitled version of the video for waiting rooms, a range of pet owner worm education materials, social media resources and SMS text message broadcasts.
Matthew Rowe, marketing manager at Elanco Animal Health, said: “Elanco is committed to encouraging responsible pet ownership; the new Milbemax advertising campaign will educate pet owners about the importance and ease of regular worming while driving them to veterinary practices for further information and to purchase pet wormers.”
For further information please contact your local Elanco Animal Health territory manager or email elancoCAH.uk@elanco.com.
Ceva Animal Health has extended its Logic range of supplements with the launch of Logic Ease for dogs and cats.
Ceva says the new ‘soft chew’ supplements contain high quality active ingredients which have been developed to ensure the high standards that owners expect for their pets, adding that they allow owners to ‘treat’ their pets, knowing they are contributing to the health of their animal and reducing the desire to give unhealthy snacks.
The range for dogs comprises Logic EaseFlex, designed to help soothe active joints and support long-term mobility; Logic EaseLife for senior dogs, designed to help support mobility, coat condition, mind vitality and alertness; Logic EaseDerm to add moisture to dry, irritated skin and help maintain a healthy, shiny coat.
The range for cats comprises Logic Easeflex and Logic EaseBall to lubricate the digestive tract and enhance the passage of fur through the gut.
Abi Busk, retail business unit manager at Ceva Animal Health said: “The new Logic supplements will provide veterinary clinics with an extensive range of veterinary strength supplements that are so tasty that they can be given as treats.”
For further information on the Logic range, contact your wholesaler, call Ceva on 01494 781510, email cevauk@ceva.com or visit http://www.logicforpets.co.uk.
Ricochet, one of the UK's leading TV production companies, is on the hunt for dogs with unique personality traits or unusual talents for a forthcoming ITV television documentary.
The hour long programme will look into the characteristics, heritage and personality traits of the most popular dogs in the UK. It'll revolve around dog owners and the extraordinary stories they have about their pets.
Ricochet says it is looking in particular for funny, heart-warming or poignant tales highlighting the bond between dogs and their owners - dogs with unique personality traits or unusual talents, and dogs which have performed amazing feats or changed lives.
If you have an extraordinary dog, or think a client might like to take part, call the Assistant Producer, Beth, on 01273 224800 or email: dogbreeds@ricochet.co.uk
Gardner Llewlyn Veterinary Recruitment and VetSurgeon.org / VetNurse.co.uk have announced the winners of a competition in which people were invited to nominate nurses for a special thanks for the work they do.
67 entries from veterinary surgeons, veterinary nurses and pet owners made it onto the shortlist.
Jonathan Lewis from Gardner Llewlyn said: "I know it's a cliche, but it really was very hard to pick an outright winner. In the end, though, we just loved the sheer enthusiasm of Peter Howarth MRCVS's nomination for Louisa Bouchard RVN (pictured right) from the New Era Veterinary Hospital, and thought it takes a very special person to inspire the ringing endorsement of her work."
The team nomination was similarly difficult to pick. However, Stephanie Fursland MRCVS's nomination for the nursing team at The Oval Pet Centre stood out as an example of how a good nursing team can have a really profound effect on other members of the practice team.
A new iPad mini is on its way to Louisa, and a case of champagne is winging its way to The Oval Pet Centre. There was also a draw amongst all the nominators to win another iPad mini, the winner of which was Val Marsh, who nominated Kate Slack RVN from Blacks Veterinary Group.
Arlo Guthrie, Editor of VetSurgeon.org and VetNurse.co.uk said: "We found a lot of the entries really rather moving and whether they came from members of the public or from colleagues in the profession, they all serve to demonstrate the importance - as if anyone needed reminding - of what a good nurse brings to the practice. The nominees should all be very proud.
"We decided that the nominations were too good to keep to ourselves, so we've published them on a publicly visible part of VetNurse (click here), with links back to the nominated practices' websites. Hopefully, it might be a nice thing for any of the nominees to add to their CV, and the links should in time result in these lovely endorsements appearing when people make a relevant search for the practice."
A group of UK-based investigators from Davies Veterinary Group and the UCL School of Pharmacy has published the results of a study which suggests Keppra (levetiracetam) shows promise for the treatment of feline audiogenic reflex seizures (FARS).
The condition, which was first documented by the same investigators last April, affects older cats which typically exhibit myoclonic seizures (brief, shock-like jerks of a muscle or a group of muscles) in response to certain high-pitched sounds. Both non-pedigree and pedigree cats (in particular, Birmans) may be affected. A range of sound stimuli has been reported, including the crinkling of tin foil and a metal spoon dropping into a ceramic feeding bowl, through to firewood spitting and even texting on a phone. While avoiding the triggering sounds can reduce the incidence of seizures, this is not always practical, so this research is potentially good news for owners of affected cats.
The study, Levetiracetam in the management of feline audiogenic reflex seizures: a randomised, controlled, open label study, has been published in the Journal of Feline Medicine and Surgery1.
It compared the efficacy of two antiepileptic drugs, levetiracetam (a relatively novel medication that has proven effective in studies of people with generalised epilepsies that experience myoclonic seizures) and the much older first generation drug phenobarbital, in 57 cats diagnosed with FARS. Cats were treated with one or other drug over a 12 week period; and owners were asked to record the date, number and type of seizures, any signs of illness, side effects and changes in activity or attitude, as well as whether they thought their cat's quality of life had improved, remained the same or deteriorated since starting the medication.
All cats receiving levetiracetam showed a reduction in the number of days that they experienced myoclonic seizures by at least half. In comparison, only 3% of cats showed the same reduction when treated with phenobarbital. The majority of reported side effects, such as lethargy and inappetence, were mild to moderate in both groups and these resolved after about 2 weeks in the cats treated with levetiracetam; in the phenobarbital group, however, side effects were relatively persistent. Owners of cats treated with phenobarbital perceived no benefit from using the medication; in contrast, all of the owners of cats treated with levetiracetam commented that their cat appeared brighter and more responsive after the first couple of weeks of treatment. Moreover, five cats treated with phenobarbital were switched to levetiracetam after the study, as their owners desired improved seizure control.
Having established that levetiracetam is an effective and well-tolerated treatment for cats with hallmark myoclonic seizures, the next step is to identify whether levetiracetam will also prevent so-called generalised tonic–clonic seizures. This is another seizure type seen in cats with FARS, and is what most people think of as a 'seizure', with the cat losing consciousness and its body stiffening and jerking, often for several minutes.
Lead author on the paper, Mark Lowrie, said: "It is great to find a medication that works so well at controlling these seizures. Levetiracetam is not licensed in cats but it has proven to be a very safe drug. For affected cats to benefit, it is important that vets recognise the signs as this newly defined syndrome of FARS and that this medication is used in preference to other, less efficacious, anti-epileptic drugs."
Reference
Kruuse has announced that it has entered into an agreement with Henry Schein Inc., under which the American supplier of veterinary, dental and medical healthcare products and services will acquire a majority shareholding in the company.
Under the agreement - the financial details of which are not being disclosed - the Kruuse family will retain the remaining shareholding and work with Henry Schein to accelerate global expansion of the company.
Kruuse and Henry Schein have already been business partners in the marketing and distribution of animal healthcare products. Kruuse says it expects the deal to create significant growth prospects, particularly for its own products and brands which will in the future be included in Henry Schein's offering to its animal health customers.
Chairman of the Board of Kruuse, Peter Eriksen Jensen said: "We are very pleased with the agreement with Henry Schein, which fulfills our wish to find a strong investor to support our efforts of creating an attractive future for our company. We complement each other extremely well - and the partnership provides us with a much broader platform to market our products. In Henry Schein, we will get an ideal partner to realize our ambitious growth strategy."
Kruuse's CEO, Jesper Smith said: "It is very important to us, that we and our new owner have a mutual understanding of the values and customer-centric focus on quality and services which have guided us throughout Kruuse's 119 years' history. We will continue this approach under our new ownership, making sure that our employees, customers, and suppliers continue to experience all the benefits of Kruuse - now in an even stronger set-up and with new, exciting prospects for the future."
Vetoquinol has launched Rimifin® a non-steroidal anti-inflammatory drug (NSAID) for dogs, containing carprofen.
Carprofen can reduce inflammation and pain caused by musculo-skeletal disorders and degenerative joint disease. It can also be used as a follow-up to parenteral analgesia in the management of post-operative pain following soft tissue surgery.
Rimifin® is available in a range of tablet sizes, 20mg, 50mg and 100mg. A single 100mg tablet can treat a 50kg dog.
Rimifin® is available from 21 January 2008, with a launch offer of three packs for the price of two. For further information speak to your Vetoquinol representative, visit http://www.vetoquinol.co.uk/ or call 0800 169 8197.
Veterinary nurse Catherine Marsh (pictured right) from Eastgate Veterinary Group in Bury St. Edmunds has become the 1000th nurse to complete the Royal Canin Pet Health Counsellor course. The three day residential training course for nurses in practice takes place four times a year, and provides training on running clinics in practice as well as canine and feline behaviour, nutrition and preventative medicine. Up to 30 delegates at a time meet to share their experiences and work together, providing a real forum for exchanges of opinion on the role and experience of vet nursing today. For more information about the Royal Canin Pet Health Counsellor scheme, please contact your Veterinary Business Manager.
The RCVS is conducting a survey of veterinary nurses, to complement the regular surveys of veterinary surgeons it carries out. You can take part by clicking the link at the foot of this article. The purpose of the survey is to take a snapshot of the veterinary nursing profession in 2008, and anticipate future trends and changes. "We hope to find out more about veterinary nurses' employment type and experiences, working patterns and professional development," according to Andrea Jeffery, Chairman of the Veterinary Nurses Council. "We will also be asking about nurses' aspirations for the short- and long-term and their current views on the profession." The survey results will help to show how the provision of veterinary services might be affected by various factors, including numbers of student veterinary nurses, career breaks, part-time working, and nurses choosing to work outside the profession. It will help the College to understand the changing role of veterinary nurses within the veterinary team, the impact of the non-statutory Register of Veterinary Nurses and to determine future training needs. It will also inform ongoing discussions about new veterinary legislation. The survey is being carried out by the Institute for Employment Studies (IES), an independent, not-for-profit research organisation. All veterinary nurses will receive a hard copy of the survey towards the end of January. It is also possible to complete it online at http://www.employmentresearch.co.uk/rcvs_vns.htm
Phil Sketchley, chief executive of the National Office of Animal Health, today called for more veterinary practices to get involved with National Pet Month (5th April to 5th May). Speaking at the annual conference of the Veterinary Practice Management Association in Bristol, he said: "Last year nearly 100 practices held events - but there are around 2000 small animal practices out there. It's a fantastic opportunity to open your doors and show your clients - and potential clients - the high level of expertise your practice has and what goes on behind the scenes. "Last year some event holders reported that new clients joined after their NPM event. And these were not clients from the practice down the road - these were owners whose pets had not previously been registered with a practice - real proof that NPM can work to improve the health and welfare of pets. "Other practices chose to go and talk to schools about pet care. This is a great way to demonstrate to children the importance of keeping their pet healthy, and the role the vet and vet nurse can play," he added. The theme for this year's National Pet Month is Great British Pets. To get ideas and promotional advice for your event, and to register it free, visit: http://www.nationalpetmonth.org.uk/
Fort Dodge (makers of Equest equine worming brands, and Deosect), is launching a new Equine Parasites Reference Manual.
The manual, which is supported by AHDA, AMTRA and BEVA, is billed as 'an objective and comprehensive reference guide covering endoparasites and ectoparasites and their control, as well as offering prescribing tips, a glossary of terms and reference sources'.
Fort Dodge has produced the manual to provide an ‘all in one' guide to support veterinary professionals and Suitably Qualified People (SQPs) involved in prescribing equine parasite treatments. It brings together, in an A5 spiral bound booklet, all the information they may need on the full range of licensed veterinary medicines to control equine parasites of concern in the UK. It will be launched at BETA (17-19 February at the NEC).
For further information about the manual (or to get a copy), please contact Fort Dodge on 01489 781711.
VN Council includes elected veterinary nurses, lay people, RCVS Council members, a Lantra representative and veterinary surgeons. “With the introduction of the non-statutory Register and recent developments in veterinary nursing training, the VN profession is going through an exciting period of change,” according to VN Council Chairman Andrea Jeffery. “We are looking for VN Council members with enthusiasm, vision and commitment to help take the profession to the next stage.” There are two vacancies for elected veterinary nurses on Council, each to serve for a four-year period. Candidates must be Registered or Listed Veterinary Nurses and be supported by two proposers, also Registered or Listed VNs. Candidates need to be prepared to spend at least six days per year on VN Council business - potentially more if they are co-opted onto other working parties and subcommittees - and be able to travel to meetings in London. Recompense for loss of earnings is offered to employers and travel expenses are paid. Nomination packs are available from Annette Amato on 020 7202 0713 or a.amato@rcvs.org.uk and must be completed and returned by 29 February. Election papers will be sent with the March issue of RCVS News and voting will close on 28 April. The newly-elected members will join VN Council at RCVS Day in July.
Hill's Pet Nutrition has announced that Canine i/dTM is now available again from wholesalers. The company says that Canine i/d has been reformulated to improve texture quality, while still retaining the nutritional profile that makes i/d ideal for dogs with digestive problems and as a post-surgery recovery diet. Hill's Prescription Diet Canine i/d Recovery Packs are back early March; Hill's recommends use of regular i/d in the interim. For more information, speak to your Territory Manager, or ring Hill's Customer Services on: 0800 282438 (UK), or: 1 800 626002 (IRL)
Pfizer Animal Health has launched Dexdomitor, a new, advanced form of the popular sedative /analgesic Domitor (medetomidine). According to Pfizer, Dexdomitor contains only the right-handed enantiomer (dexmeditomidine) which is responsible for the beneficial pharmacological effects of the meditomidine molecule. By removing the left-handed enantiomer (levomedetomidine) from the original racemic mixture the same sedative and analgesic effects can be achieved with a lower metabolic load, less potential for interaction with other drugs and half the active substance. According to Dr Jo Murrell, Senior lecturer in veterinary anaesthesia in Bristol Vet School, the use of dexmedetomidine has a number of advantages in terms of veterinary use: "Because dexmedetomidine had to undergo a lot of safety studies to get market authorisation in humans, we have a huge amount of cardiovascular data about the effects of dexmedetomidine in dogs," she said. "That means we know very precisely the effects of dexmedetomidine on cardiac output, on organ blood flow and the changes in blood flow to vital organs such as the heart and brain." Dr Murrell recommends that practices that are currently using Domitor should consider switching to Dexdomitor when it becomes available. "You won't notice any disadvantages as a result of the switch, but you may well notice that the effects of dexmedetomidine are more reliable compared to medetomidine, and you may notice some benefits in terms of recovery from anaesthetic combinations."
The RCVS is inviting comment on its proposed Return to Veterinary Nursing Practice course for veterinary nurses returning to the Register following a break of five years or more. The non-statutory Register for Veterinary Nurses was introduced in September 2007. Registration is compulsory for those VNs listing after 1 January 2003, and voluntary for others. Registered Veterinary Nurses (RVNs) signal their commitment to professionalism by agreeing to maintain their competence and skills by means of continuing professional development and abiding by the Guide to Professional Conduct for Veterinary Nurses. From 2010, a disciplinary framework for veterinary nurses will be introduced. Veterinary Nurses who have deregistered for a period of five years or more are required to complete a 17-week Period of Supervised Practice (PSP) before rejoining the Register. This ensures they have the opportunity to update their knowledge and skills under the mentorship and supervision of other registered practitioners (veterinary or veterinary nursing). To support nurses undertaking the PSP, the RCVS is developing a voluntary Return to Veterinary Nursing Practice course, which will lead to a Certificate in Current Veterinary Nursing Practice. The proposed time commitment for the course is 100 hours, including 30 "contact hours", which may be taught traditionally in a classroom or via online learning. The cost of the course will be determined by course providers. In order to ensure the course is fit for purpose, the College invites comment on its proposed structure from course providers, veterinary nurses and employers by 29 February 2008. Hard copy consultation documents have been issued to key stakeholders, but all are welcome to comment. The documentation is available to download from RCVSonline (click here) or by email from vetnursing@rcvs.org.uk. The College reserves the right to publish selected comments, together with its responses.
Bayer Animal Health has doubled the number of pipettes in its Advocate all-in-one flea, worm and mite spot-on to provide an additional range of six-month treatment packs for cats and dogs. Bayer says the doubling of the number of pipettes in a pack is aimed at providing vets with greater prescribing flexibility and to help improve compliance for owners over a six-month period. Bi-annual vet visits will now give a full year's parasite cover with Advocate. Advocate is now available in three- and six-pipette packs for small and large cats and for medium, large and extra large dogs, and three-pipette packs for small dogs. The product remains the only combined flea, worm and mite spot-on that is licensed for the treatment of A. vasorum in dogs.
Researchers at the University of Edinburgh's Royal () School of Veterinary Studies are to start testing whether a compound of cooling chemicals, extracted from mint, can be used to treat laminitis, a condition which affects seven per cent of the British horse population. The new project, funded by The Horse Trust and led by Professor Sue Fleetwood-Walker, builds on recent work that revealed for the first time that, there is significant nerve damage, as well as inflammation, within the hoof of laminitic horses. This explains why anti-inflammatory drugs are so ineffective in treating the pain of chronic laminitis and highlights the need for therapies to treat nerve injury-induced or ‘neuropathic' pain in horses. Prof Fleetwood-Walker's team discovered in 2006 that the ‘mint' chemicals have a pain-killing effect in laboratory studies of chronic pain. They will now investigate whether this synthetic treatment could help horses with laminitis.
Fort Dodge has launched a new website for horse owners, all about parasites and worming. It's here: http://www.wormingyourhorse.info/.
Two recently published studies have demonstrated that the canine anti-emetic Cerenia® (maropitant - Pfizer) which was launched last year also relieves car sickness in dogs. In a pilot study, 17 dogs were given either Cerenia or placebo one hour before being taken on a car journey. After a washout period of 10-14 days, each dog was crossed over to the other treatment and once again taken on a journey to assess travel sickness. The results showed that likelihood of vomiting was reduced by 70% when the dogs were given Cerenia compared to placebo - but due to the small number of dogs enrolled the results did not reach statistical significance. The same research group also carried out a large, multicentre, blinded and placebo controlled study of Cerenia in preventing vomiting in 213 dogs known to be prone to travel sickness. They were given a single oral dose of Cerenia or placebo one hour before a car journey. The results showed that Cerenia was associated with a reduction in vomiting of 79% compared to placebo (p<0.0001).> The dosage of Cerenia used in both studies was 8mg/kg dose for the prevention of motion sickness-higher than the 2mg/kg dose that is routinely used to treat general emesis, administered at least one hour before the journey. According to the researchers' report in the Veterinary Record, the need for a higher dose is linked to the specific neural (central) pathway of emetic stimulation that is involved in motion sickness. Cerenia acts primarily at NK1 receptors in the emetic centre and thus has the ability to block vomiting due to vestibular stimuli. According to Pfizer, a single oral dose lasts for at least 12 hours, so pets can be dosed the night before an early start. For motion sickness prevention, Cerenia is licensed for up to 2 days' consecutive use, so owners can use it for a return journey the next day if need be. Pfizer also says that market research suggests almost one in five dogs suffers from travel sickness, which is not only inconvenient but does also stop some owners from travelling with their pet. In the past, owners have had to rely on OTC (over the counter) remedies or medicines developed for use in humans to prevent travel sickness. Many of these are ineffective or have unwanted effects such as sedation or extrapyramidial effects in dogs. Cerenia is the first anti-emetic to be developed specifically for use in dogs and was launched in April 2007- higher dose tablets aimed specifically for the prevention of travel sickness are expected to be made available early this year.
Animus4Vets has launched a new complete series of training CDs. The new series of 4 CDs is entitled Sales and Merchandising and covers aspects such as Consulting room sales, Waiting room sales and Educational displays.
Animus4Vets says the new CDs have been designed in a similar format as their first Client Care series and aim to enable veterinary practices to run their own in-house training.
For more information go to http://www.animus4vets.com/ and follow the CD training links or phone 01449 775330.
Prac-tic® - the spot-on flea and tick treatment from Novartis Animal Health has added a new claim to its licence.
It now states that adult fleas are killed before they lay eggs for a minimum of four weeks after treatment and, as the product completely eliminates egg production, it also breaks the flea life cycle.
Hot on the heels of the new license claim for Prac-tic comes the news that Novartis has launched new tasty Milbemax for cats.
The new tablet is the same small size as the original, but is beef-flavoured to ensure high palatability. According to Novartis, trials show that 100 per cent of cats accept the treatment with wet food and 83 per cent with dry food.
To help promote worming the palatable way, Novartis is offering practices some tasty marketing tools to use including posters, client leaflets, worming reminder pads and even a sturdy cut-out cat for reception.
Novartis will also be running a ‘Name Our Cat' competition with the chance to win an iPod touch complete with an educational podcast; there are five to be won. Entry details can be obtained from Novartis Territory Managers.
For more information about new tasty Milbemax, please contact your Novartis Animal Health Territory Manager or call the Practice Support Line on 0800 854100.
Hill's Prescription Diet Canine r/d has been reformulated following new findings regarding the role of protein in weight loss and the development of new fibre technology. According to Hill's, trials of the new formulation resulted in some impressive results, with individual overweight animals losing at least 22% of their body fat in 8 weeks while still maintaining muscle mass. In addition, the company has developed a range of support measures to help raise awareness about obesity and encourage pet owners to come forward. There's a new website: http://www.hillsweightloss.co.uk/ containing tips on weight loss and e-mailed reminders about returning to the surgery for weight checks; a pet passport containing information on helping the pet live a longer and healthier life, an anatomy poster that describes the dangers of excess weight gain and a practice display materials kit. Libby Sheridan, Veterinary Affairs Manager at Hill's, "It can be time consuming to put together a really good wall or table display. This kit offers the opportunity for use in its entirety, while also giving scope to add individual elements for those who want to customize the display further." Hill's Prescription Diet Canine r/d will be available in 1.5Kg, 4Kg and 12Kg bags. The recipe of the current 350g can remains unchanged. For more information call Hill's Customer Service on 0800 282 438 or (ROI) 1-800 626002.
The Worldwide Veterinary Service (WVS, Charity no 1100485) is appealing to veterinary practices, equipment suppliers and pharmaceutical companies to donate unwanted supplies to its Parcel Appeal 2008.
The charity, which exists to provide a sustainable veterinary resource to assist animal charities and non-profit organisations, sends donation parcels of veterinary supplies to 138 associated animal charities around the world.
Hannah Westen, WVS International Projects Co-ordinator said: "Last year we were able to help over 50 associated charities in this way with nearly £90,000 worth of donated items. This year we hope to double this but to do so we also need help to cover postage costs."
Some parcels are sent as responses to urgent requests, where it is essential that the parcel arrives within a matter of days, while others are a way of providing assistance to charities where it is not practical to send a veterinary team. Hannah added: "Donation parcels are a simple way for WVS to provide assistance for charities and shelters in even the most remote locations. We recently sent several parcels to St. Helena, one of the most remote islands on the planet."
For further information, visit: http://www.wvs.org.uk/, telephone: 01725 551123, or email: info@wvs.org.uk.
A Pet Obesity Task Force, the first of its kind in the country, has been launched at the European Pet Obesity Conference, hosted by Hill's Pet Nutrition to help tackle the growing number of obese and overweight pets and put in place strategies to help overcome the condition. The Task Force hopes to raise awareness of the growing health implications of obese and overweight pets, such as diabetes and osteoarthritis. The fact that pets are obese or overweight is often overlooked by owners and the group also aims to encourage them to identify weight problems and seek appropriate advice from vets. Mark Evans, chief veterinary adviser at the RSPCA, who will be sitting on the board, comments: "We've been trying to treat and prevent pet obesity for 20 years, but the problem hasn't gone away. In fact it seems to have got worse despite everyone's efforts. It's incredibly frustrating. So, is there any point in fighting on in the same old way if we're not winning the battle? "Let's take a step back, review our knowledge, re-evaluate our approaches, think outside the box and innovate. What could we learn from social scientists, human psychologists and others engaged in trying to tackle the very same problem in people - especially children?" Members of the Pet Obesity Task Force include: Mark Evans, chief veterinary adviser, RSPCA BVetMed MRCVS Professor John Innes BVSc PhD CertVR DSAS(Orth) MRCVS Professor Danielle Gunn-Moore BSc BVM&S PhD MACVSc MRCVS Daniel Chan DVM DipACVECC DipACVN MRCVS Nicola Ackerman BSc(Hons) RVN Cert SAN MBVNA Rachel Casey BVMS Dip(AS)CABC MRCVS Dr Ian Campbell GP Mike Jessop BVetMed MRCVS Dr Jacques Debraekeleer DVM, DipECVCN Simon Wheeler Head of marketing at Petplan